Lyophilized Semaglutide + Cagrilintide Blend
Semaglutide + Cagrilintide is a blended research preparation containing two synthetic peptide compounds with distinct receptor profiles.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, while cagrilintide is a long-acting amylin analog. The combination provides a laboratory model for investigating GLP-1 and amylin-related receptor systems, peptide interactions, receptor signaling, and associated biochemical pathways.
| Attribute | Specification |
|---|---|
| Form | White to off-white lyophilized powder |
| Blend Ratio | Contains 2.5 mg semaglutide + 2.5 mg cagrilintide |
| Purity | ≥99% by reverse-phase HPLC |
| Molecular Weights | Semaglutide: approximately 4115 Da; Cagrilintide: approximately 4300 Da |
| CAS Number — Semaglutide | 910463-68-2 |
| Solubility | Soluble in aqueous laboratory media; solvent and buffer selection should be determined according to the requirements of the applicable research protocol |
| Storage | Store at -20°C, dry and protected from light |
Related Research Peptides
- Semaglutide — GLP-1 receptor agonist used in laboratory receptor-signaling research.
- Cagrilintide — long-acting amylin analog used in laboratory peptide-signaling research.
- Tirzepatide — dual GIP/GLP-1 receptor agonist used in laboratory receptor-signaling research.
- Retatrutide — multi-receptor agonist designed to interact with GLP-1, GIP, and glucagon receptors.
Stacy (verified owner) –
Very fast shipping
Good product
Adrian Russell (verified owner) –
Michelle Schwemmer (verified owner) –
Joleen (verified owner) –
Anonymous (verified owner) –
Appreciated the quick resolution of a problem.